Japan has its own drug safety laws which are different from those of other countries in various ways. Before a pharmaceutical product is sold in the Japanese market, it needs to pass Japan’s strict test and in getting the nod from the Japanese authority a Japanese contract research organization (CRO) can be very helpful.
Japan has taken several drug safety measures in the past years and is expected to propose new ones. Japanese authorities study ways to improve drugs and postmarketing surveillance. Among other things, Japan has standardized warning labels and has rules for product names. A Japanese contract research organization can offer professional guidance to pharmaceutical companies so that they can update their products with the changes in Japanese drug safety measures.
Pharmaceutical companies which are new to the shore of Japan can face problems due to unfamiliarity with the Japanese system. A Japanese CRO can offer special assistance to these companies who are willing to invest in the Japanese pharmaceutical market with their expertise in Japan’s drug safety measures and related fields. For setting up pharmaceutical business in Japan this assistance can be extremely beneficiary, because with sound knowledge of the Japanese system the Japanese CROs are also very familiar with drug safety measures taken by other countries, so they can guide a company in the right direction with the right kind of help. Start-up companies can also benefit from the expertise of a CRO.
Some services from contract research organizations include the preparation of a standard operating procedure in accordance with the Japanese standards. It helps in the general business processing on drug safety and offers consultancy services to pharmaceutical companies as to how they can be compliant with the drug safety measures and laws in the country. They also offer assistance with application service and risk management. In short, they offer all the guidance a pharmaceutical company needs to set up business in Japan.
Comments are closed.